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Abstract
We describe a consanguineous Iraqi family in which affected siblings had mild mental retardation and congenital ataxia
characterized by quadrupedal gait. Genome-wide linkage analysis identified a 5.8 Mb interval on chromosome 8q with
shared homozygosity among the affected persons. Sequencing of genes contained in the interval revealed a homozygous
mutation, S100P, in carbonic anhydrase related protein 8 (CA8), which is highly expressed in cerebellar Purkinje cells and
influences inositol triphosphate (ITP) binding to its receptor ITPR1 on the endoplasmatic reticulum and thereby modulates
calcium signaling. We demonstrate that the mutation S100P is associated with proteasome-mediated degradation, and thus
presumably represents a null mutation comparable to the Ca8 mutation underlying the previously described waddles
mouse, which exhibits ataxia and appendicular dystonia. CA8 thus represents the third locus that has been associated with
quadrupedal gait in humans, in addition to the VLDLR locus and a locus at chromosome 17p. Our findings underline the
importance of ITP-mediated signaling in cerebellar function and provide suggestive evidence that congenital ataxia paired
with cerebral dysfunction may, together with unknown contextual factors during development, predispose to quadrupedal
gait in humans.
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Introduction
The hereditary ataxias comprise a diverse groups of disorders
characterized by loss of balance and coordination. They are
classified as autosomal recessive, autosomal dominant, X-linked,
and mitochondrial, and are clinically and pathogenetically diverse
[1,2]. The identification of genes associated with individual forms
of ataxia has gone a long way towards the identification of factors
responsible for development, homeostasis, and function of the
cerebellum, which is the organ primarily affected in most forms of
ataxia.
Recently, a form of ataxia characterized by quadrupedal gait
has been described in several families. A syndrome of nonpro-
gressive cerebellar ataxia and mental retardation associated with
inferior cerebellar hypoplasia and mild cerebral gyral simplifica-
tion was initially identified in patients with a disorder termed
‘‘dysequilibrium syndrome’’ (MIM 224050). This disorder was
found to be due to a 199 kb deletion on chromosome 9p24
encompassing all of the very low-density lipoprotein receptor gene
(VLDLR) and part of the poorly characterized gene LOC401491
[3]. Homozygous premature-truncation-codon (PTC) mutations in
VLDLR were subsequently found to be associated with severe
ataxia, cerebellar hypoplasia, dysarthria, and severe mental
retardation. Affected persons walked on all four extremities.
Although the affected persons could stand upright and even walk
bipedally, they preferred quadrupedal walking [4,5]. An unrelated
Iranian family with a PTC mutation in VLDLR was subsequently
reported in which affected persons had mental retardation,
strabismus, short stature, disturbed equilibrium, and walking
disability, but no tendency towards quadrupedal gait [6]. A further
unrelated family with cerebellar hypoplasia, mental retardation,
and quadrupedal gait demonstrated linkage to a locus on
chromosome 17p [7].
The observation that some, but not all, VLDLR mutation
carriers walk on all four extremities raised the question of whether
quadrupedal gait is a functional adaptation that can be seen in
congenital ataxia syndromes depending on unknown internal or
external influences. Although many mammals and other animals
can stand or walk bipedally for shorter or longer periods of time,
the manner in which humans do so is unique to our species. Our
upright posture is the result of constant skeletomuscular adjust-
ments of posture. In contrast, other primates make frequent use of
‘‘holds’’ during locomotion. In effect, we are always a second or
two away from falling down. Human bipedalism and higher
cognition are closely integrated. Especially running places high
requirements on cognition, such as the need to incorporate
PLoS Genetics | www.plosgenetics.org 1 May 2009 | Volume 5 | Issue 5 | e1000487information about uneven parts of the ground ahead. Nonhuman
primates such as gorillas can only run for short distances, and
human children do not develop adult competence in walking and
running until about the age of seven years [8].
In the current work, we report on mutations in the CA8 gene in
a consanguineous family from Iraq. Affected family members
displayed a syndrome of ataxia and mild mental retardation
(AMMR) and ambulate on all four extremities (quadrupedal gait).
In contrast to the previously reported cases associated with VLDLR
mutations and with a locus on chromosome 17p, affected persons
have only mild mental retardation. Including CA8 as described in
the present report, there are now three gene loci, mutations in
which are associated with ataxia and cerebral defects, whereby
some, but not all affected persons display quadrupedal gait. We
therefore suggest that congenital ataxia together with cerebral
deficits may, together with other, currently unknown external or
internal factors, predispose to quadrupedal gait in humans.
Results
We identified an Iraqi family with a syndrome characterized by
ataxia and mild mental retardation (AMMR). The healthy parents
are first cousins, and four of eight sibs are affected. The parents
claimed that the affected persons never learned to crawl on their
knees as most infants do, but ambulated from infancy on with their
legs held straight with a ‘‘bear-like’’ gait. They also claimed that
attempts to teach the children to walk on two legs with crutches or
other supports failed. Our own observations confirm that four of
the affected children as adults are predominantly quadrupedal (see
Video S1). They walk with straight legs, placing weight on the
palms of their hands. Although the affecteds are able to walk on
two legs for several steps, they tend to tumble into a quadrupedal
position quickly, complain of lack of balance and occasionally fall
from a sitting position. Affected persons were noted to have mild
mental retardation and dysarthric, slurred speech, but there were
no other symptoms such as retinopathy or pyramidal signs. Table 1
provides an overview of the clinical features observed in the four
affected siblings encoded using terms of the Human Phenotype
Ontology [9].
We used a genome-wide linkage approach to identify the
genetic basis of AMMR in this family. We established significant
genetic linkage to a 6-centiMorgan interval on chromosome 8q12
with a lod score of 3.01 (Figure 1) This interval spans nucleotides
58,881,724–64,607,419 on chromosome 8 (March 2006, UCSC
hg18 assembly) and contains 17 protein-coding genes, including an
obvious candidate, carbonic anhydrase-related protein VIII (CA8),
which is abundantly expressed in cerebellar Purkinje cells [10].
Carbonic anhydrases are a family of monomeric zinc metalloen-
zymes that catalyze the reversible hydration of CO2. However,
CA8 lacks one of the three histidine residues required for binding
to the zinc ion and thus has no catalytic carbonic anhydrase
activity [11]. The waddles (wdl) mouse is a spontaneous animal
model with ataxia and appendicular dystonia without morpho-
logical abnormalities in the central or peripheral nervous system.
The wdl mouse was shown to harbor a 19-bp deletion in Ca8 that
leads to rapid degradation of mutant Ca8 mRNA and to the almost
complete lack of detectable Ca8 protein [12]. Although the
morphology of the cerebellum appeared normal by confocal
microscopy [12], subsequent investigations revealed abnormalities
of parallel fiber-Purkinje cell synapses in the cerebellum together
with defects in excitatory transmission [13].
We therefore sequenced all 8 exons of CA8 and identified the
homozygous transition c.298T.C, predicted to lead to the
substitution of a serine by a proline residue (S100P), in all affected
individuals (Figure 2). c.298T.C segregated correctly with the
disease in the family and was not found in 200 population-
matched controls, thus making a previously undescribed polymor-
phism unlikely. In addition, we found no other nonsynonymous
sequence changes in any of the other 16 genes in the mapping
interval, including the TTPA gene, mutations in which are found
in ataxia with vitamin E deficiency [14] (AVED).
The sole known biochemical function of CA8 is to inhibit inositol
1,4,5-triphosphate (IP3)b i n d i n gt oI P 3 receptor 1 (ITPR1) [15].
ITPR1 plays a critical role in the modulation of intracellular calcium
(Ca
2+) signaling [16]. Like CA8, ITPR1 is also highly expressed in
Purkinje cells. Mutation of Ip3r1 underlies ataxia in mice and
mutationsinITPR1 have been identified inspinocerebellar ataxia 15
in humans [17]. Interestingly, mutant ataxin-3, which is the protein
productof the gene mutated inspinocerebellar ataxia type 3 (SCA3),
was shown to bind to ITPR1 and thereby cause a destabilization of
neuronal calcium signaling [18]. These observations suggest that
disturbances of ITPR1-mediated calcium signaling may be an
important and common phenomenon in hereditary ataxias. We
therefore investigated whether S100P affects CA8-ITPR1 binding
using recombinant full-length CA8 and a region of ITPR1
containing the known CA8-binding domain [15]. No detectable
difference was observed between wildtype and mutant CA8
constructs using blot-overlay assays (Figure 3). Therefore, since the
wdl mouse displays a hypomorphic Ca8 mutation [12], we
hypothesized that S100P might affect protein stability.
HEK cells were stably transfected with Flag-tagged wildtype
and S100P mutant CA8 constructs using a system that allows
single-copy targeted integration of a tetracyclin-inducible con-
struct. This allowed us to compare the stability of mutant and
wildtype CA8 mRNA and protein at several different levels of
expression. Following selection of stable clones, the expression of
wildtype and mutant CA8 was examined using quantitative
realtime PCR, and the quantity of wildtype and mutant protein
was examined by Western blots. Whereas mRNA levels for the
mutant CA8 were not different from those of the wildtype
Author Summary
We identified a homozygous missense mutation (S100P) in
the gene encoding carbonic anhydrase VIII in a consan-
guineous Iraqi family in which affected siblings had mild
mental retardation and congenital ataxia characterized by
quadrupedal gait. The affected persons walk on their
hands and feet with their legs held straight with a ‘‘bear-
like’’ gait. Our results show that the mutation S100P
induces proteasome-mediated degradation with a severe
reduction of the level of CA8 protein. The waddles (wdl)
mouse, a spontaneous animal model with ataxia, was
previously shown to harbor a 19-bp deletion in Ca8 that
leads to an almost complete lack of detectable Ca8
protein, resulting in abnormalities in cerebellar synaptic
transmission. Therefore, we speculate that the reduction in
CA8 protein concentration associated with the S100P
mutation could result in similar pathophysiological effects.
With the current report, alterations at three gene loci (CA8,
VLDLR, and a yet-to-be discovered gene on chromosome
17p) have been reported to be associated with quadru-
pedal gait. It is unknown whether quadrupedal gait is
related to specific molecular abnormalities or is an
adaptive response to ataxia in some circumstances.
However, we note that ataxia associated with mutations
at all three loci is congenital and also associated with
mental retardation, which is not generally a feature of
other hereditary ataxias.
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being only barely detectable by Western blotting (Figure 5A). The
level of mutant CA8 protein could be partially rescued using
MG132, a proteasome inhibitor (Figure 5B). Taken together, these
results indicate that S100P causes a reduction of protein stability
owing to accelerated proteasomal degradation, which could be
related to protein misfolding or other factors.
Discussion
The cerebellum is a complex neurological structure, containing
more than half of the brain’s total number of neurons. Cerebellar
networks show long-term synaptic plasticity, which indicates that
experience-dependent adaptive and learning processes are a salient
feature of cerebellar function. Most afferent information enters the
cerebellum via climbing fibers (CF) and mossy fibers, which excite
the Purkinje cells indirectly through the parallel fiber (PF) pathway.
Binding of CA8 to ITPR1 inhibits IP3 binding to ITPR1 by
reducing the affinity of the receptor for IP3 [15]. This is one of
several factors that modulate the ability of ITPR1 to rapidly release
calcium stores from the endoplasmatic reticulum [19]. Mice with
mutations in either Ip3r1 or Ca8 do not display cerebellar atrophy,
but rather both show neurophysiological defects [20,21]. Modula-
tion of intracellular calcium is important for a number of cerebellar
functions such as long-term depression [22]. Therefore, we
speculate that the consequences of a CA8 mutation may involve
improper modulation of the ITPR1 with resultant functional and/
or developmental defects in the cerebellum.
S100P leads to a proteasome-mediated reduction in protein
stability in our in vitro assay. Loss of protein stability is a common
mechanism of missense mutations associated with human disease
[23]. We suggest that it is plausible that the mutation leads to a
reduction of the amount of CA8 in the cerebellum of the affected
individuals, which might lead to a similar defect as that observed
in the waddles mouse, in which Ca8 is nearly undetectable in
cerebellum owing to a 19 bp deletion in the gene [12].
Mutations at three loci (CA8, VLDLR and the yet-to-be discovered
geneat17p) havenow beenfound tobe associatedwithquadrupedal
locomotion in humans, although not in all affected individuals. The
clinical picture ofthedisorders associated with mutations atthethree
loci is similar but shows important differences. The affected persons
of the family described in this work showed a relatively mild degree
of mental retardation. Seizures have not been observed in the family
described in this study, but did represent a characteristic clinical
feature of the family in whom linkage to a locus on chromosome 17p
was reported [7]. Table 1 gives an overview of the clinical features
encountered in the three forms of ataxia which have been observed
with quadrupedal gait. Given the variable incidence of quadruped-
alism in individuals with mutations in the same gene, we think it
probable that contextual factors during development – either
internal or external – contribute to this particular phenotypic
outcome [24]. As one possibility, we note that ataxia associated with
mutations at all three loci is congenital and also associated with
mental retardation, which is not generally a feature of other
hereditary ataxias, such as Joubert syndrome [25] or AVED [14].
Thus, perhaps it is only when congenital ataxia is coupled to a
certain kind ofmalfunction of the cerebral cortex that individuals are
likely to remain walking on all fours.
Materials and Methods
Written informed consent was obtained from the subjects to
publish details of their case and family history including the
photograph and video documentation.
Genome-Wide Linkage Analysis
The family was genotyped using the Affymetrix GeneChipH
Human Mapping 10 K Array. The maximum expected lod score
for a first cousin marriage with 4 affected children is approx-
imately 3.01. The two-point and multipoint linkage analyses
(Genehunter [26], Allegro [27] and Merlin [28]) were performed
assuming a fully penetrant autosomal recessive trait with a disease
Table 1. Clinical features of the affected persons of the family presented in this work and summary of features found related to
mutations in VLDLR and at a locus on chromosome 17p.
HPO term CA8 VLDLR 17p
S100P ns/fs unknown
Cerebellar ataxia (HPO:0001253), Q Q/B Q/B
Cerebellar ataxia associated with quadrupedal gait (HP:0009878)
Dysarthria (HP:0001260) ++ (or no speech) +
Mental retardation, mild (HP:0001256) Mild Moderate/Severe Severe
Mental retardation, moderate (HP:0002342)
Mental retardation, severe (HP:0001261)
Tremor (HP:0001337) ++ /2 +
Seizures (HP:0001250) 2 very rare +/2
Strabismus (HP:0000486) +/2 ++
Cerebellar hypoplasia (HPO:0001321) n/a ++
Cortical gyral simplification (HPO:0009879) n/a ++
Corpus callosum hypoplasia (HPO:0002079) n/a 2 +
The features are coded using terms from the Human Phenotype Ontology [9]. Abbreviations: Q: quadrupedal gait (HPO:0001253); B: cerebellar ataxia with bipedal gait
(annotated as HPO:0001253). Q/B: some affecteds show quadrupedal gait, some bipedal; Mild: mild mental retardation (HP:0001256), Moderate: moderate mental
retardation (HP:0002342); severe: severe mental retardation (HP:0001261). +: present, 2: absent; +/2: present in some, absent in other affected persons. ns/fs:
Information summarized for nonsense/frameshift mutations in VLDLR R257X [4], c2339delT [4,5] and R448X [6]. Information for the 17p locus summarized from ref. [7].
n/a: information not available.
doi:10.1371/journal.pgen.1000487.t001
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using the easyLINKAGE and easyLINKAGE-Plus tools [29,30].
Recombinant Constructs
All PCRs were performed using High-Fidelity Taq Polymerase
(Invitrogen). Two large amplicons comprising the full-length
human CA8 transcript and a region of ITPR1 containing the
known CA8-binding domain [15] (amino acids 1387–1647) of
ITPR1 were amplified by PCR from human fibroblast cDNA. A
CA8 amplicon corresponding to positions +91 to +1190 (number-
ing based on GenBank entry AY075022) was amplified using the
primers 59- tgcactcacactgcggttca-39 (f) and 59- aagggcattataggac-
cact-39 (r). An ITPR1 amplicon corresponding to positions +4361
to +5270 (numbering based on GenBank entry L38019) was
amplified using the primers 59-ctcatgtaccacatccactt-3 (f) and 59-
ccttaatgcagagcttctct-39 (r).
Figure 1. Abbreviated pedigree showing the inferred haplotypes of the parents and the four affected children. The SNPs A-1511204
and A-1509289 are homozygous in the mother and therefore noninformative for the maternally derived recombination in this region. Therefore,
these markers were not fully informative with respect to the critical recombination on the maternally inherited haplotype in affected individual II-1.
doi:10.1371/journal.pgen.1000487.g001
CA8 Mutations and AMMR Syndrome
PLoS Genetics | www.plosgenetics.org 4 May 2009 | Volume 5 | Issue 5 | e1000487We first produced CA8 and ITPR1 constructs for investigation of
protein-protein binding. A recombinant CA8 construct correspond-
ing to the complete coding region of human CA8 was then amplified
by nested PCR with the primers 59-gtatGGATCCgatggcggacct-
gagcttca-39 (f) and 59- cttgCTCGAGctactgaaatgcagctctaa-39 (r).
Similarly, a recombinant ITPR1 was amplified with the primers 59-
gtatGGATCCgaagaatgtctacacagaga-39 (f) and 59-cttgCTCGAGt-
tatttcacatttccttctggcgt-39 (r). The resulting fragments were sub-
cloned into the plasmid pFastBac HT A (Invitrogen) using the
BamH1 and Xho1 restriction sites (capitalized in the primer
sequences). pFastBac HT A adds a hexa-histidine tag and an rTEV
protease cleavage site to the N-terminus of the expressed protein.
The c.298T.C (S100P) mutant CA8 construct was prepared by
using the GeneTailor Site-Directed Mutagenesis kit (Invitrogen)
using the primers 59- tcaaaatcagttcttCcgggaggaccattgc-39 (f) and
59-aagaactgattttgacttcaggataacctga-39 (r) according to the manu-
facturer’s protocol.
Additional Flag-tagged CA8 constructs were produced for
investigation of the influence of S100P on protein stability. PCR
amplification of the full-length wild-type or S100P mutant CA8-
pFastBac HT A constructs was used to subcloned to the BamH1
and Xho1 sites of pcDNA3 (Invitrogen) using the primers 59-
gtatGGATCCatggcggacctgagcttca-39 (f) and 59-tgCTCGAGc-
tacttgtcatcgtcgtccttgtagtcctgaaatgcagctct-39 (r). The reverse primer
introduces the Flag tag sequence DYKDDDDK to the C-terminus
of the CA8 protein. pcDNA5/FRT/TO Flp-In constructs were
then obtained by subcloning Flag-CA8(WT) and Flag-CA8(S100P)
from pcDNA3.1 into the pcDNA5/FRT/TO vector using the
BamH1 and Xho1 restriction sites. All resulting recombinant
vectors were verified by sequencing.
Figure 2. CA8 Mutations in two families with ataxia and mild
mental retardation. (A) Affected members of an Iraqi family
displayed quadrupedal gait. (B) Sequence traces of the mutation
c.298T.C (S100P) in CA8 and a wildtype control (wt). (C) Sequence logo
of an alignment of CA8 orthologs from 12 species from human to sea
urchin showing the sequence affected by S100P. Position 100 does not
show a high degree of conservation.
doi:10.1371/journal.pgen.1000487.g002
Figure 3. Blot overlay analysis of CA8-ITPR1 binding. A
recombinant fibrillin-1 fragment rFib47
wt [32] was used as negative
control (2).
doi:10.1371/journal.pgen.1000487.g003
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CA8 Binding Domain of ITPR1
Spodoptera frugiperda (Sf9) cells were maintained in serum-free
Insect-Xpress medium (Biowhittaker) supplemented with 5% fetal
bovine serum, 10 U/ml penicillin, and 10 mg/ml streptomycin,
and cultured at 27uC.
The production of the protein was performed according to the
protocol of the Bac-to-Bac Baculovirus expression system (Invitrogen).
Briefly,therecombinantpFastBacHTAvectorsweretransformedinto
E. coli DH10Bac cells (Invitrogen). The isolated positive recombinant
bacmids were verified by PCR and used to transfect Sf9 insect cells for
viral particle formation. Following three rounds of amplification of
baculovirus, the virus titer was determined by plaque assay.
Small scale time-course expression experiments were conducted
in 6 well plates to optimize the multiplicity of infection (MOI) and
expression time. Bands corresponding to the size of recombinant
protein were visualized on Western blots by detection with
monoclonal anti-His6 antibody (Novagen). For large-scale pro-
duction of protein, 5610
8 Sf9 cells were infected at an MOI of 1
plaque-forming unit (pfu)/cell with recombinant baculovirus. After
about 48 hours cells were harvested and resuspended in 10 ml
lysis buffer (10 mM Tris-HCl, 10 mM Imidazol, 256EDTA free
protease inhibitor cocktail (Sigma-Aldrich), 0.1 mM PMSF),
sonication was performed on ice for 2615 s at 50% maximum
energy output and was cleared by centrifugation at 12,000 rpm for
30 min. Purification of the recombinant protein was performed as
described before [31]. Concentration of the recombinant poly-
peptide was determined with the BCA protein assay (Pierce)
according to the manufacturer’s instruction.
Blot Overlay Assay
For the blot overlay assay, recombinant wildtype and S100P
mutant CA8 were separated by sodium dodecyl sulfate-12%
polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred
onto a polyvinylidene difluoride (PVDF) membrane (Immobilon-P
transfer membrane, Millipore). A recombinant fibrillin-1 fragment
[32] was used as a control. Non-specific binding sites were blocked
with dilution buffer (ProFound Far-Western Biotinylated Protein:-
Protein Interaction Kit, Pierce), according to the manufacturer’s
instructions, and incubation was performed for 2 h at room
temperature with 2 mg/ml of the biotinylated ITPR1 fragment in
dilution buffer and was followed by washing the PVDF membrane
three times with PBS including 0.025% Tween 20. For detection,
incubation was performed with streptavidin-horseradish peroxidase
conjugate for 3 h at room temperature. Membranes were washed six
times in 16PBS including 0.025% Tween 20. Membranes werethen
incubated in the UnBlot substrate working solution (ProFound Far-
Western Biotinylated Protein:Protein Interaction Kit, Pierce).
Hyperfilm ECL chemiluminescence films (Amersham Pharmacia)
were exposed according to the manufacturer’s instructions.
Generation of Stable Flp-In T-REx 293 Cells Expressing
Flag-CA8(WT) and Flag-CA8(S100P)
To generate stable tetracycline-inducible Flp-In T-REx cells,
0.5 mg pcDNA/FRT/TO encoding Flag-CA8(WT) or Flag-
CA8(S100P)] or empty pcDNA/FRT/TO and 1 mg pOG44 were
cotransfected into Flp-In T-REx 293 cells (1610
6) using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
directions. 48 hours after transfection cells were reseeded at less
than 25% confluence, after 4 hours, the medium was changed to
medium supplemented with 100 mg/ml hygromycin B (Invitrogen)
and 15 mg/ml blasticidin. After two weeks, hygromycin-resistant
colonies were picked and sub-cultured. Selection of positive
colonies was performed by immunoblotting as described below.
Detection of mRNA by Quantitative RT-PCR
Tetracycline inducible Flip-In T-REx 293 cells were grown in
the absence or presence of 1 mg/ml tetracycline for 24 hours, total
Figure 4. Relative expression levels of Flag-CA8 WT and S100P, tetracycline-inducible Flip-In T-REx-293 cells were grown in the
absence or presence of 1 mg/ml tetracycline for 24 hours. GAPDH was used to normalize the individual expression levels (run in triplicate).
There is no significant difference between the mRNA levels of mutant or wildtype CA8. n.s.: Non-significant.
doi:10.1371/journal.pgen.1000487.g004
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(Macherey-Nagel, Duren, Germany) according to the manufac-
turer’s protocol. 1 mg RNA from cells was reverse-transcribed
using the Superscript First Strand synthesis kit (Invitrogen).
Quantitative RT-PCR was performed on an ABI Prism 7500
Sequence Detection System using SYBR-Green PCR Master Mix
at 50uC for 2 min, 95uC for 10 min, then 40 cycles at 95uC for
15 s, and at 60uC for 1 min. The forward primer for CA8 is
complementary to a sequence at the C-terminal region of CA8,5 9-
cttgtggaaggctgtgatgg-39, and the reverse primer is complementary
to a sequence of the Flag tag, 59-ttgtcatcgtcgtccttgtag-39. The
primer pair for amplification of GAPDH was: 59-ctcaacgaccactttgt-
caagctca-39,5 9-ggtcttactccttggaggccatgtg-39.
Immunoblotting to Detect Flag-CA8 Proteins
To detect the expression of CA8-Flag WT and S100P protein,
tetracycline-inducible Flip-in T-REx cells seeded in 24 well plate
(2610
5) were induced by 0.1 mg/ml or 1 mg/ml tetracycline
(Sigma-Aldrich). To inhibit the proteasome, cells were incubated
in proteasome inhibitor MG132 (Sigma-Aldrich) at different
concentrations (0.4 mM, 2.0 mM) in the presence of 1 mg/ml
tetracycline. After 24 hours cells were washed twice with PBS and
lysed with 100 mlo f1 6 SDS-sample buffer (50 mM Tris-HCL
pH 6.8, 10% glycerol, 2% SDS, 1% 2-mercaptoethanol, 0.02%
Bromphenol blue). After brief sonication on ice, 10 ml aliquots were
separated on 12% SDS-gel and electrophoretically transferred to a
PVDF membrane. Immunodetection was performed by using
mouse monoclonal anti-Flag (1:2000, Sigma-Aldrich) as primary
antibody, followed by subsequent incubation with HRP (horserad-
ish peroxidase)-conjugated rabbit anti-mouse secondary antibody
(1:2000, Calbiochem). Parallel Western blots were probed with a
mouseanti-GAPDH antibody(1:5000,Abcam)asa loading control.
Protein expression was quantified using the ImageJ program [33].
CA8 Sequence Logos
A CA8 protein multiple alignment from Human (Homo sapiens;
NP_004047), dog (Canis familiaris; XP_544094), cow (Bos taurus;
NP_001077159), horse (Equus caballus; XP_001496523), mouse (Mus
musculus; NP_031618), rat (Rattus norvegicus; NP_001009662), opos-
sum (Monodelphis domestica; XP_001368351), chicken (Gallus gallus;
XP_419221), frog (Xenopus (Silurana) tropicalis; NP_001011213), trout
(Oncorhynchus mykiss; NP_001118116), zebrafish (Danio rerio;
NP_001017571), and sea urchin (Strongylocentrotus purpuratus;
XP_795365) was prepared with ClustalX [34] and sequence logos
were prepared using texshade [35].
Supporting Information
Video S1 Film demonstrating quadrupedal gait of one of the
families described in this manuscript.
Found at: doi:10.1371/journal.pgen.1000487.s001 (1.94 MB
WMV)
Figure 5. The mutation S100P reduces CA8 protein stability by means of proteasome-mediated CA8 degradation. (A) Reduction of
CA8 protein concentration by S100P. Production of wildtype and mutant CA8 was induced by tetracycline. There was a strong reduction in the level
of mutant CA8 protein compared to that of the wildtype at both 0.1, and 1.0 mg/ml tetracycline. *: Pv0:05, **: Pv0:01, comparison between mutant
and wildtype at the indicated tetracycline concentration by two-sided t-test. The expression is represented as signal intensity ratio between CA8/
GAPDH, which was normalized to the WT level induced by 1 mg/ml tetracycline. Mean values6standard deviation (SD) in triplicate experiments are
shown. (B) Rescue of mutant CA8 protein expression by proteasomal inhibition. Addition of the proteasome inhibitor MG132 lead to a dose-
dependent rescue of CA8 concentration. *: Pv0:05, comparison between 0 mM MG132 and 0.4 mM or 2.0 mM MG132. Expression is shown as ratio
relative to that of the mutant CA8 protein (S100P) without MG132. Mean values6SD in triplicate experiments are shown.
doi:10.1371/journal.pgen.1000487.g005
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